Silence Therapeutics (LON:SLN) Stock Price Passes Below 200 Day Moving Average of $535.00

Silence Therapeutics plc (LON:SLNGet Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 535 ($6.72) and traded as low as GBX 512 ($6.43). Silence Therapeutics shares last traded at GBX 535 ($6.72), with a volume of 913,528 shares.

Silence Therapeutics Stock Performance

The company has a debt-to-equity ratio of 0.80, a current ratio of 4.52 and a quick ratio of 4.36. The company’s 50-day moving average price is GBX 535 and its two-hundred day moving average price is GBX 535. The company has a market capitalization of £480.35 million and a price-to-earnings ratio of -11.01.

About Silence Therapeutics

(Get Free Report)

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver.

Featured Stories

Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.